Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review.

Nunes LV, Moreira HC, Razzouk D, Nunes SO, Mari Jde J.

J Sex Marital Ther. 2012;38(3):281-301. doi: 10.1080/0092623X.2011.606883. Review.

PMID:
22533871
2.

Management of sexual dysfunction due to antipsychotic drug therapy.

Schmidt HM, Hagen M, Kriston L, Soares-Weiser K, Maayan N, Berner MM.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD003546. doi: 10.1002/14651858.CD003546.pub3. Review.

PMID:
23152218
3.

Management of sexual dysfunction due to antipsychotic drug therapy.

Berner MM, Hagen M, Kriston L.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003546. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD003546.

PMID:
17253492
4.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
5.

Change in sexual dysfunction with aripiprazole: a switching or add-on study.

Mir A, Shivakumar K, Williamson RJ, McAllister V, O'Keane V, Aitchison KJ.

J Psychopharmacol. 2008 May;22(3):244-53. doi: 10.1177/0269881107082901.

PMID:
18308789
6.

Sexual dysfunction in schizophrenia: focus on recent evidence.

Baggaley M.

Hum Psychopharmacol. 2008 Apr;23(3):201-9. doi: 10.1002/hup.924. Review.

PMID:
18338766
7.

A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophrenia.

Costa AM, Lima MS, Mari Jde J.

Sao Paulo Med J. 2006 Sep 7;124(5):291-7. Review.

8.
9.

Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.

Byerly MJ, Marcus RN, Tran QV, Eudicone JM, Whitehead R, Baker RA.

Schizophr Res. 2009 Feb;107(2-3):218-22. doi: 10.1016/j.schres.2008.09.019. Epub 2008 Nov 26.

PMID:
19038534
10.

Aripiprazole in schizophrenia and schizoaffective disorder: A review.

Stip E, Tourjman V.

Clin Ther. 2010;32 Suppl 1:S3-20. doi: 10.1016/j.clinthera.2010.01.021. Review.

PMID:
20152550
11.

A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed.

Berner MM, Hagen M, Kriston L.

J Clin Psychiatry. 2006 Oct;67(10):1649-50. Review. No abstract available.

PMID:
17107261
12.

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.

Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L'Italien G, McQuade RD, Beuzen JN.

Eur Psychiatry. 2007 Oct;22(7):433-43. Epub 2007 Jun 7.

PMID:
17555947
13.

Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.

Lu ML, Shen WW, Chen CH.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1978-81. doi: 10.1016/j.pnpbp.2008.09.016. Epub 2008 Sep 30.

PMID:
18848860
14.

Prolactin awareness: an essential consideration for physical health in schizophrenia.

Montejo AL.

Eur Neuropsychopharmacol. 2008 May;18 Suppl 2:S108-14. doi: 10.1016/j.euroneuro.2008.02.004. Review.

PMID:
18346598
15.

Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.

Jeong HG, Lee MS, Lee HY, Ko YH, Han C, Joe SH.

Int Clin Psychopharmacol. 2012 Jul;27(4):177-83. doi: 10.1097/YIC.0b013e328351c8c4.

PMID:
22407277
16.

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW.

J Clin Psychiatry. 2002 Sep;63(9):763-71.

PMID:
12363115
17.
18.

Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.

Kinon BJ, Ahl J, Liu-Seifert H, Maguire GA.

Psychoneuroendocrinology. 2006 Jun;31(5):577-88. Epub 2006 Feb 20.

PMID:
16488084
19.

An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

Krzystanek M, Krupka-Matuszczyk I.

Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Review.

PMID:
23055416
20.

Benefits of switching women schizophrenic patients to aripiprazole: a case study and brief review of the literature.

Kuloglu M, Ekinci O, Albayrak Y, Caykoylu A.

Arch Womens Ment Health. 2010 Oct;13(5):443-7. doi: 10.1007/s00737-010-0150-x. Epub 2010 Feb 24.

PMID:
20179976
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk